Morocco Faces Gardonale Shortage

Epilepsy patients in Morocco are facing a crisis due to the depletion of the "Gardinal 50 mg" medication stock in pharmacies, which jeopardizes their health stability—especially for those who rely on it regularly for treatment. Support organizations have not received any official explanation for its disappearance, nor have measures been taken to ensure the medication’s return to the market. This situation heightens concerns among families, threatens the continuity of treatment, and increases the risk of health complications.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article